154 related articles for article (PubMed ID: 36375226)
1. Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formation.
Laizure SC; Chen F; Farrar JE; Ali D; Yang B; Parker RB
Drug Metab Pharmacokinet; 2022 Dec; 47():100479. PubMed ID: 36375226
[TBL] [Abstract][Full Text] [Related]
2. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
Laizure SC; Parker RB; Herring VL; Hu ZY
Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
[TBL] [Abstract][Full Text] [Related]
3. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
[TBL] [Abstract][Full Text] [Related]
4. Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism.
Hu ZY; Parker RB; Herring VL; Laizure SC
Anal Bioanal Chem; 2013 Feb; 405(5):1695-704. PubMed ID: 23239178
[TBL] [Abstract][Full Text] [Related]
5. Impact of endogenous esterase activity on in vitro p-glycoprotein profiling of dabigatran etexilate in Caco-2 monolayers.
Ishiguro N; Kishimoto W; Volz A; Ludwig-Schwellinger E; Ebner T; Schaefer O
Drug Metab Dispos; 2014 Feb; 42(2):250-6. PubMed ID: 24212377
[TBL] [Abstract][Full Text] [Related]
6. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
8. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
Thomsen R; Rasmussen HB; Linnet K;
Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
[TBL] [Abstract][Full Text] [Related]
9. Effects of alcohol on human carboxylesterase drug metabolism.
Parker RB; Hu ZY; Meibohm B; Laizure SC
Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro.
Imai S; Ichikawa T; Sugiyama C; Nonaka K; Yamada T
J Pharm Sci; 2019 Feb; 108(2):1027-1034. PubMed ID: 30267780
[TBL] [Abstract][Full Text] [Related]
11. Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny.
Hines RN; Simpson PM; McCarver DG
Drug Metab Dispos; 2016 Jul; 44(7):959-66. PubMed ID: 26825642
[TBL] [Abstract][Full Text] [Related]
12. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Merali Z; Ross S; Paré G
Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
[TBL] [Abstract][Full Text] [Related]
13. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
[TBL] [Abstract][Full Text] [Related]
14. Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver.
Kobayashi Y; Fukami T; Shimizu M; Nakajima M; Yokoi T
Drug Metab Dispos; 2012 Jun; 40(6):1080-4. PubMed ID: 22446520
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of LC-MSMS assay for the determination of the prodrug dabigatran etexilate and its active metabolites in human plasma.
Nouman EG; Al-Ghobashy MA; Lotfy HM
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():37-45. PubMed ID: 25797721
[TBL] [Abstract][Full Text] [Related]
16. The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and Its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate.
Udomnilobol U; Jianmongkol S; Prueksaritanont T
Drug Metab Dispos; 2023 Sep; 51(9):1216-1226. PubMed ID: 37230768
[TBL] [Abstract][Full Text] [Related]
17. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.
Zhu HJ; Appel DI; Johnson JA; Chavin KD; Markowitz JS
Biochem Pharmacol; 2009 Apr; 77(7):1266-72. PubMed ID: 19185566
[TBL] [Abstract][Full Text] [Related]
18. Examination of the carboxylesterase phenotype in human liver.
Ross MK; Borazjani A; Wang R; Crow JA; Xie S
Arch Biochem Biophys; 2012 Jun; 522(1):44-56. PubMed ID: 22525521
[TBL] [Abstract][Full Text] [Related]
19. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
Ishizuka T; Yoshigae Y; Murayama N; Izumi T
Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
[TBL] [Abstract][Full Text] [Related]
20. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review.
Liu Y; Li J; Zhu HJ
Expert Opin Drug Metab Toxicol; 2024 May; 20(5):377-397. PubMed ID: 38706437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
